Evidence mapPaperPMID 37511618Full record

ArticleInternational journal of molecular sciences2023

Low-Density Lipoprotein Receptor (LDLR) Is Involved in Internalization of Lentiviral Particles Pseudotyped with SARS-CoV-2 Spike Protein in Ocular Cells.

Sheetal Uppal, Olga Postnikova, Rafael Villasmil, Igor B Rogozin, Alexander V Bocharov, Thomas L Eggerman, Eugenia Poliakov, T Michael Redmond

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Sheetal UppalLaboratory of Retinal Cell & Molecular Biology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0002-3685-8602
Olga PostnikovaLaboratory of Retinal Cell & Molecular Biology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Rafael VillasmilFlow Cytometry Core Facility, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0002-8956-2979
Igor B RogozinNational Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894, USA.ORCID 0000-0003-0802-4851
Alexander V BocharovClinical Center, National Institutes of Health, Bethesda, MD 20894, USA.
Thomas L EggermanClinical Center, National Institutes of Health, Bethesda, MD 20894, USA.
Eugenia PoliakovLaboratory of Retinal Cell & Molecular Biology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0003-3865-8054
T Michael RedmondLaboratory of Retinal Cell & Molecular Biology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0002-1813-5291
National Institutes of Health · USNational Institutes of Health Clinical Center · US

Funding

Molecular Biology Of Outer Retina-specific ProteinsZIAEY000260 · NATIONAL EYE INSTITUTE · 2025 to 2025
$1.9M
Flow Cytometry COREZICEY000457 · NATIONAL EYE INSTITUTE · 2025 to 2025
$430k
Biochemistry of SARS-CoV-2 Spike Protein and its Ocular Surface Membrane ReceptorZIAEY000577 · NATIONAL EYE INSTITUTE · 2025 to 2025
$306k
NEI NIH HHS Intramural Research Program
6 · The paper itself

Abstract

Here, we present evidence that caveolae-mediated endocytosis using LDLR is the pathway for SARS-CoV-2 virus internalization in the ocular cell line ARPE-19. Firstly, we found that, while Angiotensin-converting enzyme 2 (ACE2) is expressed in these cells, blocking ACE2 by antibody treatment did not prevent infection by SARS-CoV-2 spike pseudovirions, nor did antibody blockade of extracellular vimentin and other cholesterol-rich lipid raft proteins. Next, we implicated the role of cholesterol homeostasis in infection by showing that incubating cells with different cyclodextrins and oxysterol 25-hydroxycholesterol (25-HC) inhibits pseudovirion infection of ARPE-19. However, the effect of 25-HC is likely not via cholesterol biosynthesis, as incubation with lovastatin did not appreciably affect infection. Additionally, is it not likely to be an agonistic effect of 25-HC on LXR receptors, as the LXR agonist GW3965 had no significant effect on infection of ARPE-19 cells at up to 5 μM GW3965. We probed the role of endocytic pathways but determined that clathrin-dependent and flotillin-dependent rafts were not involved. Furthermore, 20 µM chlorpromazine, an inhibitor of clathrin-mediated endocytosis (CME), also had little effect. In contrast, anti-dynamin I/II antibodies blocked the entry of SARS-CoV-2 spike pseudovirions, as did dynasore, a noncompetitive inhibitor of dynamin GTPase activity. Additionally, anti-caveolin-1 antibodies significantly blocked spike pseudotyped lentiviral infection of ARPE-19. However, nystatin, a classic inhibitor of caveolae-dependent endocytosis, did not affect infection while indomethacin inhibited only at 10 µM at the 48 h time point. Finally, we found that anti-LDLR antibodies block pseudovirion infection to a similar degree as anti-caveolin-1 and anti-dynamin I/II antibodies, while transfection with LDLR-specific siRNA led to a decrease in spike pseudotyped lentiviral infection, compared to scrambled control siRNAs. Thus, we conclude that SARS-CoV-2 spike pseudovirion infection in ARPE-19 cells is a dynamin-dependent process that is primarily mediated by LDLR.

Indexed as

COVID-19Spike Glycoprotein, CoronavirusAngiotensin-Converting Enzyme 2BenzoatesBenzylaminesCholesterolClathrinDynamin IIHumansLipoproteins, LDLReceptors, LDLSARS-CoV-2Virus InternalizationAngiotensin-Converting Enzyme 2BenzoatesBenzylaminesCholesterolClathrinDynamin IIGW 3965LDLR protein, humanLipoproteins, LDLReceptors, LDLSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2ARPE-19LDLRLDL receptorlow-density lipoprotein receptorocular cellsSARS-CoV-2spike proteinS-protein

Identifiers

PMID37511618
PMCPMC10380832
OpenAlexW4385255552

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.